- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.43 Å
- Oligo State
- monomer
- Ligands
- 1 x KNW: (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3- dihydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.3: 5 residues within 4Å:- Chain A: Y.111, L.149, I.150, S.153
- Ligands: KNW.1
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.111, A:Y.111, A:Y.111, A:L.149, A:I.150
OLC.4: 9 residues within 4Å:- Chain A: L.48, L.62, I.66, L.69, L.70, S.73, W.140
- Ligands: OLA.10, OLA.15
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.48, A:L.62, A:L.69, A:W.140
- 21 x OLA: OLEIC ACID(Non-covalent)
OLA.5: 7 residues within 4Å:- Chain A: Q.183, Y.187, L.190, V.191, L.195, F.199
- Ligands: OLA.6
Ligand excluded by PLIPOLA.6: 4 residues within 4Å:- Chain A: L.195, F.198, F.199
- Ligands: OLA.5
Ligand excluded by PLIPOLA.7: 12 residues within 4Å:- Chain A: N.63, S.67, L.70, F.71, Y.100, S.101, N.105, W.140, W.147, M.151
- Ligands: OLA.10, OLA.14
Ligand excluded by PLIPOLA.8: 8 residues within 4Å:- Chain A: F.20, V.28, I.31, K.368, I.372, L.376, F.383
- Ligands: OLA.13
Ligand excluded by PLIPOLA.9: 8 residues within 4Å:- Chain A: V.37, G.41, L.42, Y.45, A.402, L.403, K.405
- Ligands: OLA.22
Ligand excluded by PLIPOLA.10: 5 residues within 4Å:- Chain A: L.70, W.140
- Ligands: OLC.4, OLA.7, OLA.14
Ligand excluded by PLIPOLA.11: 6 residues within 4Å:- Chain A: L.30, F.33, F.34, D.80, L.83
- Ligands: OLA.21
Ligand excluded by PLIPOLA.12: 6 residues within 4Å:- Chain A: G.91, D.92, L.93, A.94
- Ligands: OLA.16, OLA.20
Ligand excluded by PLIPOLA.13: 5 residues within 4Å:- Chain A: F.20, E.23, F.24, V.28
- Ligands: OLA.8
Ligand excluded by PLIPOLA.14: 5 residues within 4Å:- Chain A: W.140, G.144, W.147
- Ligands: OLA.7, OLA.10
Ligand excluded by PLIPOLA.15: 3 residues within 4Å:- Chain A: L.48
- Ligands: OLC.4, OLA.22
Ligand excluded by PLIPOLA.16: 6 residues within 4Å:- Chain A: F.77, I.89, F.90, G.91
- Ligands: OLA.12, OLA.17
Ligand excluded by PLIPOLA.17: 3 residues within 4Å:- Chain A: I.89, F.90
- Ligands: OLA.16
Ligand excluded by PLIPOLA.18: 1 residues within 4Å:- Chain A: Y.205
Ligand excluded by PLIPOLA.19: 3 residues within 4Å:- Chain A: T.330, I.333, F.390
Ligand excluded by PLIPOLA.20: 2 residues within 4Å:- Chain A: L.93
- Ligands: OLA.12
Ligand excluded by PLIPOLA.21: 4 residues within 4Å:- Chain A: F.77, D.80, R.84
- Ligands: OLA.11
Ligand excluded by PLIPOLA.22: 5 residues within 4Å:- Chain A: I.44, L.48, Q.49
- Ligands: OLA.9, OLA.15
Ligand excluded by PLIPOLA.23: 5 residues within 4Å:- Chain A: F.340, P.345, L.366, A.369, T.373
Ligand excluded by PLIPOLA.24: 2 residues within 4Å:- Chain A: F.199, L.207
Ligand excluded by PLIPOLA.25: 2 residues within 4Å:- Chain A: L.341, F.383
Ligand excluded by PLIP- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)
- Release Date
- 2019-12-11
- Peptides
- Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.43 Å
- Oligo State
- monomer
- Ligands
- 1 x KNW: (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3- dihydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 2 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 21 x OLA: OLEIC ACID(Non-covalent)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)
- Release Date
- 2019-12-11
- Peptides
- Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.